open access

Vol 80, No 4 (2022)
Original article
Published online: 2022-02-13
Get Citation

Influence of a long-term proctoring process on the effectiveness of chronic total occlusion percutaneous coronary interventions

Katarzyna Żelazowska-Chmielińska1, Wojciech Wąsek2, Mirosław Ferenc3, Bogumił Kamiński4, Tomasz Przerwa1, Paweł Krzesiński1
DOI: 10.33963/KP.a2022.0042
·
Pubmed: 35152395
·
Kardiol Pol 2022;80(4):445-451.
Affiliations
  1. Department of Cardiology and Internal Diseases, Military Institute of Medicine in Warsaw, Warszawa, Poland
  2. Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland
  3. Department of Cardiology and Angiology II, University Heart Center Freiburg in Bad Krozingen, Germany
  4. SGH Warsaw School of Economics, Warszawa, Poland

open access

Vol 80, No 4 (2022)
Original article
Published online: 2022-02-13

Abstract

Background: Despite the complexity of the chronic total occlusion (CTO) percutaneous coronary intervention (PCI) procedures and unsatisfactory results in centers with low volume experience, the practice of training and certifying operators is not a routine.
Aims: The study aimed to identify factors influencing the effectiveness and complications of PCI CTOs during a proctoring program.
Methods: The study group consisted of 194 consecutive patients (226 PCI CTOs) as part of the proc-toring program. The relationships between clinical and treatment parameters and the experience gained along with the duration of the proctoring program on the effectiveness and safety of the procedure were assessed.
Results: The multivariable analysis showed an independent effect of CTO morphology (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.21–0.71; P <0.01) and an independent effect of increasing operator’s experience (OR, 2.62; 95% CI, 1.24–5.60; P = 0.01) on the effectiveness of the procedure. The increase in the efficiency of the PCI CTO, related to the treatment experience gained during the program, was observed especially in the first 50 procedures, treatment effectiveness increased from 55% to 72% (P <0.05). The success of procedures was higher in months when ≥3 procedures were performed (75% vs. 52%; P <0.001). Periprocedural complications occurred in 11 patients (4.9%). In the multivariable analysis, no independent factors influencing the risk of complications were identified.
Conclusions: The effectiveness of PCI CTO depended on lesion complexity and broadening oper-ator’s experience. No independent factors affecting the risk of complications were identified. The number of >50 procedures under the proctor’s supervision should be considered in designing teaching programs.

Abstract

Background: Despite the complexity of the chronic total occlusion (CTO) percutaneous coronary intervention (PCI) procedures and unsatisfactory results in centers with low volume experience, the practice of training and certifying operators is not a routine.
Aims: The study aimed to identify factors influencing the effectiveness and complications of PCI CTOs during a proctoring program.
Methods: The study group consisted of 194 consecutive patients (226 PCI CTOs) as part of the proc-toring program. The relationships between clinical and treatment parameters and the experience gained along with the duration of the proctoring program on the effectiveness and safety of the procedure were assessed.
Results: The multivariable analysis showed an independent effect of CTO morphology (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.21–0.71; P <0.01) and an independent effect of increasing operator’s experience (OR, 2.62; 95% CI, 1.24–5.60; P = 0.01) on the effectiveness of the procedure. The increase in the efficiency of the PCI CTO, related to the treatment experience gained during the program, was observed especially in the first 50 procedures, treatment effectiveness increased from 55% to 72% (P <0.05). The success of procedures was higher in months when ≥3 procedures were performed (75% vs. 52%; P <0.001). Periprocedural complications occurred in 11 patients (4.9%). In the multivariable analysis, no independent factors influencing the risk of complications were identified.
Conclusions: The effectiveness of PCI CTO depended on lesion complexity and broadening oper-ator’s experience. No independent factors affecting the risk of complications were identified. The number of >50 procedures under the proctor’s supervision should be considered in designing teaching programs.

Get Citation

Keywords

chronic total occlusion, experience, percutaneous coronary intervention, proctoring, success

About this article
Title

Influence of a long-term proctoring process on the effectiveness of chronic total occlusion percutaneous coronary interventions

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 4 (2022)

Article type

Original article

Pages

445-451

Published online

2022-02-13

Page views

3332

Article views/downloads

300

DOI

10.33963/KP.a2022.0042

Pubmed

35152395

Bibliographic record

Kardiol Pol 2022;80(4):445-451.

Keywords

chronic total occlusion
experience
percutaneous coronary intervention
proctoring
success

Authors

Katarzyna Żelazowska-Chmielińska
Wojciech Wąsek
Mirosław Ferenc
Bogumił Kamiński
Tomasz Przerwa
Paweł Krzesiński

References (27)
  1. Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document. Circulation. 2019; 140(5): 420–433.
  2. Galassi AR, Werner GS, Boukhris M, et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention. 2019; 15(2): 198–208.
  3. Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015; 8(2): 245–253.
  4. Nikolakopoulos I, Patel T, Jefferson BK, et al. Complications of chronic total occlusion percutaneous coronary intervention. Neth Heart J. 2021; 29(1): 60–67.
  5. Karatasakis A, Brilakis ES. Chronic total occlusion percutaneous coronary intervention failure: Learning from failure. Catheter Cardiovasc Interv. 2019; 93(6): 1039–1040.
  6. Christopoulos G, Karmpaliotis D, Alaswad K, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015; 198: 222–228.
  7. Sapontis J, Salisbury AC, Yeh RW, et al. Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017; 10(15): 1523–1534.
  8. Råmunddal T, Hoebers LP, Hoebers L, et al. Chronic total occlusions in Sweden — A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One. 2014; 9(8): e103850.
  9. Suzuki Y, Tsuchikane E, Katoh O, et al. Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusion Performed by Highly Experienced Japanese Specialists: The First Report From the Japanese CTO-PCI Expert Registry. JACC Cardiovasc Interv. 2017; 10(21): 2144–2154.
  10. Nikolakopoulos I, Vemmou E, Karacsonyi J, et al. Latest developments in chronic total occlusion percutaneous coronary intervention. Expert Rev Cardiovasc Ther. 2020; 18(7): 415–426.
  11. Parma R, Zembala MO, Dąbrowski M, et al. Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society…. Kardiol Pol. 2017; 75(9): 937–964.
  12. Grygier M, Wojakowski W, Smolka G, et al. Left atrial appendage occlusion: consensus document of Association of Cardiovascular Interventions and Heart Rhythm Section of Polish Cardiac Society. Kardiol Pol. 2018; 76(3): 677–697.
  13. Kramer DB, Kesselheim AS, Kramer DB, et al. Regulation of medical devices in the United States and European Union. N Engl J Med. 2012; 366(9): 848–855.
  14. Dhruva SS, Redberg RF. FDA regulation of cardiovascular devices and opportunities for improvement. J Interv Card Electrophysiol. 2013; 36(2): 99–105.
  15. Jarow JP, Baxley JH. Medical devices: US medical device regulation. Urol Oncol. 2015; 33(3): 128–132.
  16. Yamamoto M, Tsuchikane E, Kagase Ai, et al. Novel proctorship effectively teaches interventionists coronary artery chronic total occlusion lesions. Cardiovasc Revasc Med. 2018; 19(4): 407–412.
  17. Sharma V, Jadhav ST, Harcombe AA, et al. Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions. Open Heart. 2015; 2(1): e000228.
  18. Habara M, Tsuchikane E, Muramatsu T, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheter Cardiovasc Interv. 2016; 87(6): 1027–1035.
  19. Tanaka H, Morino Y, Abe M, et al. Impact of J-CTO score on procedural outcome and target lesion revascularisation after percutaneous coronary intervention for chronic total occlusion: a substudy of the J-CTO Registry (Multicentre CTO Registry in Japan). EuroIntervention. 2016; 11(9): 981–988.
  20. Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC: Cardiovascular Interventions. 2011; 4(2): 213–221.
  21. Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013; 6(2): 128–136.
  22. Bryniarski L, Opolski MP, Wójcik J, et al. Chronic total occlusion percutaneous coronary intervention in everyday clinical practice - an expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society. Adv Interv Cardiol. 2021; 17(1): 6–20.
  23. Christopoulos G, Kandzari DE, Yeh RW, et al. Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score. JACC Cardiovasc Interv. 2016; 9(1): 1–9.
  24. Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score. JACC Cardiovasc Interv. 2019; 12(4): 335–342.
  25. Danek BA, Karatasakis A, Karmpaliotis D, et al. Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS CTO) Complications Score. J Am Heart Assoc. 2016; 5(10).
  26. Maeremans J, Spratt JC, Knaapen P, et al. Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score. Catheter Cardiovasc Interv. 2018; 91(2): 192–202.
  27. Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015; 115(10): 1367–1375.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl